Officiële publicaties ABIONYX Pharma

Aandelen

Beurs gesloten - Euronext Paris Andere beurzen 17:35:24 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,024 ^EUR	+0,59%		-4,66%	-20,50%

11/03	ABIONYX Pharma SA rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
15/02	ABIONYX Pharma SA bevestigt de klinische resultaten van de Fase 3-studie Aegis-Ii die de doeltreffendheid en veiligheid evalueert van CSL Behring's menselijk plasma-afgeleide apoA-I, CSL112.	CI

Annual results	11/03	CO
Annual results	11/03	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	31/01	CO
Changes in management and corporate officers	08/01	CO
Changes in management and corporate officers	08/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	30/11	CO
Threshold crossings	30/11	CO
3rd quarter turnover	16/11	CO
3rd quarter turnover	16/11	CO
Monthly statement on voting rights	31-10-23	CO
Monthly statement on voting rights	31-10-23	CO
Threshold crossings	11-10-23	CO
Threshold crossings	10-10-23	CO
Admission of new securities	06-10-23	CO
Admission of new securities	06-10-23	CO
Monthly statement on voting rights	30-09-23	CO
Monthly statement on voting rights	30-09-23	CO
1st-half-year results	26-09-23	CO
1st-half-year results	26-09-23	CO
Half-year report	26-09-23	CO
Monthly statement on voting rights	19-09-23	CO